Nasal Specimen Collection Study in Patients With ILI and/or ARI in an Outpatient Setting

Lieselot Houspie

Status: Unknown

Conditions: Influenza-like Illness; Influenzal Acute Respiratory Infection

Study type: Observational

Funder types: Other

Identifiers

NCT01687816

S53729

Details and patient eligibility

About

This is a prospective specimen collection study targeting patients presenting with Influenza Like Illness (ILI) and/or Acute Respiratory Infection (ARI) in an out-patient setting. A non-invasive, user friendly sampling technique, using midturbinate flocked swabs will be used. These nasal swabs will be collected in different volumes of viral transport media (0.5mL and 3.0mL), for different dilution range of the viruses present in the collected biological specimen. The collection of nasal swabs samples will support the optimization of point of care detection methods for respiratory viruses responsible for ILI and/or ARI.

Enrollment: 300 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or Female
• All Ages
• Valid Informed Consent and/or Assent, where applicable
• Onset of ILI and/or ARI within the last 3 days (≤ 72h)
• Patient presented with ILI and/or ARI

Exclusion criteria

• Invalid Informed Consent and/or Assent
• Onset of ILI and/or ARI was > 3 days (> 72 h)
• Patient did not presented with neither ILI or ARI
• Patient received intranasal attenuated influenza virus in last 3 weeks (example FluMist®, Fluenz®)
• Patient received treatment with influenza direct antivirals in the last 7 days

Trial design

300 participants in 1 patient group

No interventions to be administered

Description:

Only a nasal swab is collected, no therapeutic interventions